Caredx Inc

CDNA NASDAQ Healthcare & Biotech United States US14167L1035
20.22 $
0.39 %

Caredx Inc provides specialized diagnostic solutions, primarily tests for the monitoring of patients who have undergone organ transplantation.

Price history of Caredx Inc
Price history of Caredx Inc

Performance & Momentum

6 Months 28.30 %
1 Year 14.24 %
3 Years 165.70 %
5 Years 72.94 %

Strategic Analysis

Caredx Inc • 2026

CareDx is a specialized diagnostics player focused on transplantation, with recognized expertise in the immunological and clinical monitoring of transplant patients. Its niche positioning allows it to stand out through high-value tests supported by recurring and critical medical needs.

Strengths
  • Specialized positioning in a niche market with high clinical intensity
  • Exposure to recurring post-transplant monitoring needs, supporting durable demand
  • Recent value creation track record materially stronger than its long-term history
Weaknesses
  • Highly sensitive to commercial execution and the pace of test adoption
  • A stock profile still marked by a long history of underperformance
Momentum

Momentum appears favorable and confirms a renewed investor interest, with solid recent performance across several intermediate time horizons. This improvement suggests a phase of normalization or re-rating for the stock, but it still needs to be monitored to confirm the company’s ability to turn this share price recovery into a durable fundamental trend.

Similar stocks to Caredx Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone